You have 9 free searches left this month | for more free features.

PD-L1

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bowel Disease Trial in Japan (NPO-13: l-menthol)

Completed
  • Bowel Disease
  • NPO-13: l-menthol
  • Kitakyushu, Fukuoka, Japan
  • +12 more
Aug 13, 2020

Immune Resistance Interrogation Study

Recruiting
  • Cancer
  • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 7, 2022

    Severe Mental Illness, Lifestyle Trial in Amersfoort (GOAL!)

    Not yet recruiting
    • Severe Mental Illness
    • Lifestyle
    • GOAL!
    • Amersfoort, Utrecht, Netherlands
      GGz Centraal
    Oct 31, 2022

    Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma Trial in Worldwide (Eflornithine, Lomustine)

    Active, not recruiting
    • Anaplastic Astrocytoma
    • Recurrent Anaplastic Astrocytoma
    • Birmingham, Alabama
    • +78 more
    Jan 19, 2022

    Healthy Volunteers Trial in Glendale, San Antonio (E2814, E2814-matched )

    Recruiting
    • Healthy Volunteers
    • Glendale, California
    • +1 more
    Aug 2, 2022

    Neuroendocrine Carcinoma of the Lung and Thymus Trial in Worldwide (Pasireotide LAR, Everolimus, Pasireotide LAR and Everolimus

    Completed
    • Neuroendocrine Carcinoma of the Lung and Thymus
    • Pasireotide LAR
    • +2 more
    • Aarhus, Denmark
    • +35 more
    Mar 8, 2021

    Disposable Bronchoscopes for Research Bronchoalveolar Lavage

    Completed
    • Healthy
    • Bronchoalveolar Lavage validation study
    • Liverpool, United Kingdom
      Royal Liverpool Hospital Clinical Research Facility
    Jun 6, 2022

    MDD Trial in Boston (GeneSight Psychotropic test, Canadian Network for Mood and Anxiety Treatment (CANMAT) Best Practice

    Completed
    • Major Depressive Disorder
    • GeneSight Psychotropic test
    • Canadian Network for Mood and Anxiety Treatment (CANMAT) Best Practice Guidelines
    • Boston, Massachusetts
      Massachusetts General Hospital
    Apr 5, 2022

    Metabolic Syndrome Trial in Charlottesville (Low Intensity Exercise + Metformin, High Intensity Exercise + Metformin, Low

    Active, not recruiting
    • Metabolic Syndrome
    • Low Intensity Exercise + Metformin
    • +3 more
    • Charlottesville, Virginia
      University of Virginia
    Dec 6, 2022

    Immunotherapy Trial in Xuzhou (CAR-T cell immunotherapy)

    Recruiting
    • Immunotherapy
    • CAR-T cell immunotherapy
    • Xuzhou, Jiangsu, China
      Affiliated Hospital of Xuzhou Medical University
    Apr 26, 2022

    Neonatal Anemia Trial in Iowa City (Epoetin Alpha, Biotinylated Red Blood Cells)

    Completed
    • Neonatal Anemia
    • Epoetin Alpha
    • Biotinylated Red Blood Cells
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Apr 28, 2021

    Multiple Myeloma Trial in Japan, United States (JNJ-68284528)

    Completed
    • Multiple Myeloma
    • JNJ-68284528
    • Phoenix, Arizona
    • +20 more
    Oct 5, 2022

    CArdioversion of Short Duration Atrial Fibrillation

    Unknown status
    • Atrial Fibrillation
    • +2 more
      • Quebec City, Canada
      • +2 more
      Apr 16, 2020

      Hepatocellular Carcinoma, Portal Vein Occlusion, Tumor Thrombus Trial in Guangzhou (TACE combined with iodine-125 seeds

      Active, not recruiting
      • Hepatocellular Carcinoma
      • +2 more
      • TACE combined with iodine-125 seeds implantation
      • TACE
      • Guangzhou, Guangdong, China
        The 2nd Affiliated Hospital of Guangzhou Medical University
      Mar 2, 2022

      Duration of Treatment and Response in Multiple Myeloma or

      Recruiting
      • Multiple Myeloma
      • Immunoglobulin Light-chain Amyloidosis
        • Cadiz, Andalucia, Spain
        • +13 more
        Dec 21, 2021

        Motor Network Physiology

        Recruiting
        • Parkinson Disease
        • Essential Tremor
        • Dallas, Texas
          UT Southwestern Medical Center
        Feb 28, 2022

        Periodontal Bone Loss, Periodontal Diseases Trial in Cairo (L-PRF, OFD, CM)

        Completed
        • Periodontal Bone Loss
        • Periodontal Diseases
        • L-PRF
        • +2 more
        • Cairo, Egypt
          Ainshams University
        Aug 11, 2022

        Liver Carcinoma, Liver Transplant; Complications Trial in Shanghai (Durvalumab Injection, Lenvatinib 4 MG)

        Recruiting
        • Liver Carcinoma
        • Liver Transplant; Complications
        • Durvalumab Injection
        • Lenvatinib 4 MG
        • Shanghai, China
          Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
        Sep 19, 2020

        Hematological Malignancies Trial in Worldwide (Teclistamab)

        Recruiting
        • Hematological Malignancies
        • Birmingham, Alabama
        • +80 more
        Jan 27, 2023

        Crohn's Disease Trial in Worldwide (PF-00547659 SC injection)

        Completed
        • Crohn's Disease
        • PF-00547659 SC injection
        • Jonesboro, Arkansas
        • +136 more
        May 11, 2021

        Locally Advanced Unresectable Gastric Cancer Trial in Guangzhou (Pemigatinib)

        Not yet recruiting
        • Locally Advanced Unresectable Gastric Cancer
        • Guangzhou, Guangdong, China
          Cancer center of SunYat-sen University
        Aug 11, 2023

        Rheumatoid Arthritis Trial in France, Monaco (infliximab, etanercept, adalimumab, abatacept, rituximab or tocilizumab)

        Completed
        • Rheumatoid Arthritis
        • infliximab, etanercept, adalimumab
        • abatacept, rituximab or tocilizumab
        • Amiens, France
        • +43 more
        Aug 5, 2021

        Prostate Cancer Trial in Worldwide (Standard of Care)

        Recruiting
        • Prostate Cancer
        • Standard of Care
        • Birmingham, Alabama
        • +107 more
        Aug 17, 2022

        Anxiety Depression Trial (Mindfulness-based cognitive therapy using neuroscience (NMBCT))

        Not yet recruiting
        • Anxiety Depression
        • Mindfulness-based cognitive therapy using neuroscience (NMBCT)
        • (no location specified)
        Jun 9, 2023

        Ulcerative Colitis Trial in Worldwide (Mirikizumab, Placebo)

        Active, not recruiting
        • Ulcerative Colitis
        • Mirikizumab SC
        • +2 more
        • Dothan, Alabama
        • +399 more
        Nov 2, 2022